Peter Gengo

About Peter Gengo

An accomplished, highly motivated biochemical analytical pharmacologist with extensive in vivo and in vitro knowledge and experience in the drug discovery and early drug development process. Vast experience in business development and business strategy. A solid record of advancing small molecules, peptides and gene therapy through PK/PD and translational preclinical studies and into clinical development in the areas of cardiovascular, metabolic, pain, CNS, and urogenital diseases. Prominent scientist with over 30 years of research and leadership experience in large and small pharmaceutical companies leading multi-functional development teams in discovery, toxicology, biotechnology, drug metabolism, pharmacokinetics, analytical, bioanalytical, regulatory affairs, clinical, and business development. A strategic thinker with excellent analytical and problem solving skills in external research collaborations, due diligence licensing and acquisition teams, and evaluation of licensing packages. Familiar with FDA and FDA advisory committee meeting interactions. A skillful blend of academic scientist, passionate innovator and ultimate scientific communicator that has authored numerous scientific publications, patents and delivered scientific presentations across the United States and internationally. Dr. Gengo is currently an adjunct associate professor of cardiology at the North Carolina State University College of Veterinary Medicine.

Experience

1. Vice President

   Renova Therapeutics

   Jan 2017 — Present · San Diego, CA, US

Education

• University at Buffalo Pharmacy and Pharmaceutical Sciences

  Doctor of Philosophy - PhD, Biochemical Pharmacology

  1980 — 1986

Skills

• Pharmacodynamics
• Clinical Development
• Cell Biology
• Animal Models
• Biochemistry
• Cell
• Pharmaceutical Industry
• Drug Development
• Drug Discovery
• In Vivo
• Pharmacology